Cerenkov luminescence imaging is an emerging technique that combines aspects of both optical and nuclear imaging. An antitumor study in this issue of JNM has confirmed the dynamic sensitivity of this new modality and its correlation with PET findings. The technique provides a preclinical alternative to expensive PET instrumentation that should allow for higher cost-to-return benefits in the drug discovery process.
See page 1764.